The aim of this study was to investigate whether MYO18A has prognostic value in patients treated for brain gliomas.<h4>Methods</h4>The research material in the work included tumor samples taken during neurosurgery and blood samples from 45 patients treated for brain gliomas with grade of 1 to 4 according to WHO, which were used to determine the expression of <i>MYO18A</i> mRNA (messenger ribonucleic acid). Here, MYO18A is linked to neoplasm.